Stacked
LongevityResearch profile

Vilon

KE Peptide · Lys-Glu · Khavinson Dipeptide

Think of it as a tiny coach for your immune system.

Vilon is like a tiny personal trainer for your immune system. This little peptide has a knack for encouraging your immune cells to keep performing well, even as you age. It's like giving your body's defense team a pep talk, helping them stay sharp and responsive.

Imagine Vilon as a gentle guide that whispers to your genes and helps them express themselves in a more youthful way. Some research suggests it can interact directly with your DNA, potentially influencing how your body manages the aging process.

Studies, mostly out of Russia, hint that Vilon might play a role in helping older animals live longer, healthier lives. While these findings are intriguing, they're still waiting for more research outside of their original context to confirm just how effective Vilon might be for humans.

Who it's for

  • Biohackers curious about longevity hacks
  • Middle-aged adults looking to support their immune system
  • Those exploring peptides for anti-aging effects
  • People interested in cutting-edge, experimental health strategies

Probably not for you if…

  • Anyone uncomfortable with limited human research
  • Individuals seeking well-documented, mainstream supplements
  • People with concerns about using peptides derived from Russian research

Editorial summary for research context · Not medical advice

Mechanism of Action

Vilon is a synthetic dipeptide (Lys-Glu) from the Khavinson short-peptide bioregulator program. It is among the shortest bioactive peptides in the Khavinson catalog and research suggests it modulates gene expression through direct interaction with specific DNA/histone regions, supports T-cell maturation in immunosenescent models, and influences age-associated gene expression patterns in aged rodents. Russian preclinical and clinical cohort literature reports effects on immune parameters and lifespan markers in aged experimental animals. Human data outside Khavinson-group cohorts remains sparse.

Researched Benefits

Immune modulation in aging

Aged rodent models report improved T-cell subset balance and response to antigen challenge following administration.

  • [Khavinson et al. 2007]

Gene expression and chromatin interaction

In vitro research suggests direct binding to specific DNA sequences, with implications for age-associated gene expression modulation under the Khavinson bioregulator framework.

  • [Khavinson et al. 2011]

Geroprotective signals in rodents

Russian lifespan-extension studies in aged rodents report modulation of age-associated mortality curves versus control. Research suggests these findings warrant independent replication.

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

Standard Khavinson cycle

Dosage
5 mg
Frequency
once daily
Timing
morning
Cycle
2 weeks

Russian research protocols commonly use 10-20 consecutive days of subcutaneous dosing, 1-2 times per year. Often paired with other Khavinson bioregulators such as Epithalon or Thymalin.

Low-dose extended research

Dosage
3 mg
Frequency
every other day
Timing
morning
Cycle
4 weeks

Alternate-day dosing used in longer observation windows focused on immune parameters.

Reported Side Effects

  • Injection-site irritation
  • Rare mild allergic reactions reported
  • Long-term safety data outside Russian literature is limited

Contraindications

  • Pregnancy and lactation
  • Active malignancy
  • Autoimmune disease in active flare

Stacking Partners

Peptides commonly paired with Vilon in published research and protocol write-ups.

Vendor Pricing

Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.

Top Videos

Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.

Research Papers

  • Peptides and aging: peptide regulation of cellular aging

    Khavinson VKh, Malinin VV · Neuroendocrinology Letters · 2005

    PubMed 16010277
  • Effects of peptide Lys-Glu on thymic function in old animals

    Khavinson VKh, Kvetnoy IM, Ashapkin VV, et al. · Bulletin of Experimental Biology and Medicine · 2011